May 13, 2017 article Quantitative cell-free circulating EGFR mutation concentration is correlated with tumor burden in advanced NSCLC patients Lung Cancer DOI: 10.1016/j.lungcan.2017.05.005 OpenAlex Authors 0 Author list not loaded yet. Cited by 2 stored of 33 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study 2025 Lung Cancer article Medicine Lung Cancer Treatments and Mutations Open access 2 citations Longitudinal Circulating Tumor DNA–Guided Resistance Analysis During Second-Line Osimertinib Treatment 2025 JTO Clinical and Research Reports article Medicine Lung Cancer Treatments and Mutations Open access 1 citations 2 results References 0